Drug Profile
RVT 702
Alternative Names: RVT-702Latest Information Update: 21 Jan 2019
Price :
$50
*
At a glance
- Originator Roivant Sciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 21 Jan 2019 Discontinued - Preclinical for Unspecified in USA (Roivant Sciences pipeline, January 2019)
- 18 Jul 2017 Preclinical trials in Undefined indication in USA (unspecified route) (Roivant Sciences pipeline, July 2017)